These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29527636)

  • 1. Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder.
    de Leon J; Spina E
    Curr Psychiatry Rep; 2018 Mar; 20(3):17. PubMed ID: 29527636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of mood stabilizers].
    Zaratiegui R
    Vertex; 2003; 14 Suppl Spec():37-42. PubMed ID: 12888858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of lithium in the treatment of bipolar disorder in late-life.
    D'Souza R; Rajji TK; Mulsant BH; Pollock BG
    Curr Psychiatry Rep; 2011 Dec; 13(6):488-92. PubMed ID: 21847537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
    Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
    CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].
    Bánki CM
    Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the obsessive-compulsive and bipolar disorders comorbidity: pharmacodynamic and pharmacokinetic evaluation.
    Marazziti D; Mucci F; Avella MT; Dell'Oste V; Baroni S; Dell'Osso L
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):619-631. PubMed ID: 31271537
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
    Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
    Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant treatment considerations regarding lithium use in bipolar disorder.
    Richardson T; Macaluso M
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1105-1113. PubMed ID: 28965429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The armamentarium of treatments for bipolar disorder: a review of the literature.
    Cousins DA; Young AH
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):411-31. PubMed ID: 17176493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
    Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
    Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.